The Interferon (IFN) family of cytokines are produced in direct response to virus infection and they constitute the first line of defence against virus infection by inducing hundreds of interferon stimulated genes (ISGs) which act in concert to establish the so-called “antiviral state”. Influenza A viruses and parainfluenza virus type 5 (PIV5) are both small negative strand RNA viruses that must circumvent their hosts’ interferon (IFN) response for replication. However, the ways in which these viruses interact with the IFN system are very different. Although PIV5 replication is initially severely impaired in cells in a pre-existing IFN-induced antiviral state, it manages to overcome the antiviral state by targeting an essential component of type I IFN signalling, STAT1, for degradation. Thus the cells cannot maintain the antiviral state indefinitely without continuous signalling. Consequently, the virus resumes its normal replication pattern after 24-48 hours post-infection. In clear contrast, influenza virus fails to establish its replication in the majority of infected cells (90-95%) with a pre-existing IFN-induced antiviral state, although a few cells are still able to produce viral antigens. To further investigate how influenza virus interacts with cells in a pre-existing IFN-induced antiviral state, I have used in situ hybridization to follow the fate of input and progeny genomes in cells that have, or have not, been treated with IFN prior to infection. Here I show for the first time that IFN pre-treatment blocks the nuclear import of influenza A virus genome, which prevents the establishment of virus replication, but this can be overcome by increasing multiplicities of infection. Of those IFN-induced antiviral molecules, human MxA is an essential component of the IFN-induced antiviral state in blocking influenza virus genome import, as this block can be abolished by lentivirus-mediated knockdown of MxA. I also show that in cells constitutively expressing MxA the viral genome still manages to be transported into the nucleus, indicating that MxA might require an unidentified IFN-induced factor to block nuclear import of the influenza virus genome. These results reveal that IFN exerts its action at an early stage of virus infection by inducing MxA to interfere with the transport of viral genome into the nucleus, which is the factory for viral RNA production.

Codirecteur de recherche: Dr Sylvain Meloche / Durant ces quatre dernières années, le champ de recherche concernant l’immunité innée a grandement été influencé par la découverte des IKK-related kinases, TBK1 et IKKi, deux kinases régulant l’activité des facteurs de transcription IRF-3/IRF-7 et NF-κB. Les kinases TBK1 and IKKi furent notamment démontrées comme étant responsables de la phosphorylation en C-terminal de IRF-3. Toutefois, l’identité des sites phosphoaccepteurs ciblés par ces kinases restait un sujet de controverse. En combinant la spectrométrie de masse aux essais de phosphorylation in vitro de His-IRF-3 par la kinase recombinante TBK1, nous démontrons que les sérines 396 et 402 sont directement phosphorylées par cette kinase. Nos analyses biochimiques révèlent également que la mutation S396A, localisée dans le cluster II, abolit l’homodimérisation, l’association à CBP et l’accumulation nucléaire de IRF-3. De façon intéressante, la mutation de la sérine 339, impliquée dans la stabilité de IRF-3, provoque également une perte d’association à CBP et de la dimérisation du facteur de transcription sans toutefois affecter la transactivation des gènes antiviraux en autant que la sérine 396 soit disponible pour accepter un événement de phosphorylation. Nos expériences de complémentation de MEFs IRF-3 KO révèlent la présence d’un mécanisme compensatoire impliquant la sérine 339 et la sérine 396 dans l’induction des IFN-stimulated genes (ISGs), ISG56 and ISG54. Globalement, les données présentées dans cette étude nous ont permis de reconsidérer le modèle d’activation du facteur de transcription IRF-3 actuellement proposé et d’y ajouter certaines subtilités. TRAF3 est également un médiateur central impliqué dans l’induction de la réponse interféron de type I. Cette fois, en couplant la spectrométrie de masse à la technique de purification protéique par affinité, nous avons identifié Sec16A et p115, deux protéines du système de transport vésiculaire ER-Golgi , comme étant des nouveaux partenaires protéiques de Flag-TRAF3. Nos expériences démontrent la localisation cellulaire de TRAF3 au niveau du système de transport vésiculaire. De plus, la diminution des niveaux d’expression de p115 ou Sec16A provoque une redistribution cellulaire de TRAF3 et affecte la réponse interféron suivant une stimulation par de l’ARN double brin. Nos résultats démontrent également une colocalisation de TRAF3 et TRADD au niveau du cis-Golgi ainsi qu’une interaction avec la protéine du translocon Sec61β médiée par l’intermédiaire de Sec5. De façon générale, nos données suggèrent que la localisation cellulaire de TRAF3 au niveau des compartiments de transport vésiculaire est requise afin d’obtenir une réponse antiviral optimale par la voie de signalisation cellulaire associée aux RIG-I-like RNA helicases, RIG-I et MDA5. Nos données appuient également le rôle potentiel précédemment suggéré de l’exocyste dans l’établissement d’une réponse antivirale. / Over the past four years, the field of the innate immune response has been highly influenced by the discovery of the IκB kinase (IKK)-related kinases, TBK1 and IKKi, which regulate the activity of IRF-3/IRF-7 and NF-κB transcription factors. The IKK-related kinases, TBK1 and IKKi, were recently shown to be responsible for the C-terminal phosphorylation of IRF-3. However, the identity of the phosphoacceptor site(s) targeted by these two kinases remains unclear. By combining mass spectrometry analysis to in vitro kinase assays using full length His-IRF3 as a substrate, we have demonstrated that serine 402 and serine 396 were directly targeted by TBK1. Analysis of Ser/Thr to Ala mutants revealed that S396A mutation, located in cluster II, abolished IRF-3 homodimerization, CBP association and nuclear accumulation. Interestingly, mutation of serine 339, which is involved in IRF-3 stability, also abrogated CBP association and dimerization without affecting gene transactivation as long as serine 396 remained available for phosphorylation. Complementation of MEFs IRF-3 KO also reveals a compensatory mechanism of serine 339 and serine 396 in the ability of IRF-3 to induce IFN-stimulated genes (ISGs) ISG56 and ISG54 expression. These data lead us to reconsider the current model of IRF-3 activation. TRAF3 is also a central mediator that is important for inducing type I interferon production in response to intracellular double-stranded RNA. By combining Flag-Affinity purification using Flag-TRAF3 as a bait to mass spectrometry, we have identified Sec16A and p115, two proteins of the ER-to-Golgi vesicular transport system, as novel TRAF3 interactors. We found that TRAF3 localizes to the ER-to-Golgi vesicular pathway and behaves like a cis-Golgi protein. Depletion of p115 or Sec16A disrupts the cis-Golgi cellular localization of TRAF3 and affects type I Interferon response following double-stranded RNA treatment. Furthermore, we demonstrate that TRAF3 colocalizes with TRADD at the cis-Golgi and also interacts with the translocon protein Sec61β in a Sec5 dependent manner. Together, our data suggest that the cellular localization of TRAF3 to the ER-to-Golgi transport compartments is required for an optimal RIG-I-like Helicases (RLH)-Cardif-dependent antiviral immune response. Our findings also highlight the potential role of the exocyst in the innate immune response.

Durant ces quatre dernières années, le champ de recherche concernant l’immunité innée a grandement été influencé par la découverte des IKK-related kinases, TBK1 et IKKi, deux kinases régulant l’activité des facteurs de transcription IRF-3/IRF-7 et NF-κB. Les kinases TBK1 and IKKi furent notamment démontrées comme étant responsables de la phosphorylation en C-terminal de IRF-3. Toutefois, l’identité des sites phosphoaccepteurs ciblés par ces kinases restait un sujet de controverse. En combinant la spectrométrie de masse aux essais de phosphorylation in vitro de His-IRF-3 par la kinase recombinante TBK1, nous démontrons que les sérines 396 et 402 sont directement phosphorylées par cette kinase. Nos analyses biochimiques révèlent également que la mutation S396A, localisée dans le cluster II, abolit l’homodimérisation, l’association à CBP et l’accumulation nucléaire de IRF-3. De façon intéressante, la mutation de la sérine 339, impliquée dans la stabilité de IRF-3, provoque également une perte d’association à CBP et de la dimérisation du facteur de transcription sans toutefois affecter la transactivation des gènes antiviraux en autant que la sérine 396 soit disponible pour accepter un événement de phosphorylation. Nos expériences de complémentation de MEFs IRF-3 KO révèlent la présence d’un mécanisme compensatoire impliquant la sérine 339 et la sérine 396 dans l’induction des IFN-stimulated genes (ISGs), ISG56 and ISG54. Globalement, les données présentées dans cette étude nous ont permis de reconsidérer le modèle d’activation du facteur de transcription IRF-3 actuellement proposé et d’y ajouter certaines subtilités. TRAF3 est également un médiateur central impliqué dans l’induction de la réponse interféron de type I. Cette fois, en couplant la spectrométrie de masse à la technique de purification protéique par affinité, nous avons identifié Sec16A et p115, deux protéines du système de transport vésiculaire ER-Golgi , comme étant des nouveaux partenaires protéiques de Flag-TRAF3. Nos expériences démontrent la localisation cellulaire de TRAF3 au niveau du système de transport vésiculaire. De plus, la diminution des niveaux d’expression de p115 ou Sec16A provoque une redistribution cellulaire de TRAF3 et affecte la réponse interféron suivant une stimulation par de l’ARN double brin. Nos résultats démontrent également une colocalisation de TRAF3 et TRADD au niveau du cis-Golgi ainsi qu’une interaction avec la protéine du translocon Sec61β médiée par l’intermédiaire de Sec5. De façon générale, nos données suggèrent que la localisation cellulaire de TRAF3 au niveau des compartiments de transport vésiculaire est requise afin d’obtenir une réponse antiviral optimale par la voie de signalisation cellulaire associée aux RIG-I-like RNA helicases, RIG-I et MDA5. Nos données appuient également le rôle potentiel précédemment suggéré de l’exocyste dans l’établissement d’une réponse antivirale. / Over the past four years, the field of the innate immune response has been highly influenced by the discovery of the IκB kinase (IKK)-related kinases, TBK1 and IKKi, which regulate the activity of IRF-3/IRF-7 and NF-κB transcription factors. The IKK-related kinases, TBK1 and IKKi, were recently shown to be responsible for the C-terminal phosphorylation of IRF-3. However, the identity of the phosphoacceptor site(s) targeted by these two kinases remains unclear. By combining mass spectrometry analysis to in vitro kinase assays using full length His-IRF3 as a substrate, we have demonstrated that serine 402 and serine 396 were directly targeted by TBK1. Analysis of Ser/Thr to Ala mutants revealed that S396A mutation, located in cluster II, abolished IRF-3 homodimerization, CBP association and nuclear accumulation. Interestingly, mutation of serine 339, which is involved in IRF-3 stability, also abrogated CBP association and dimerization without affecting gene transactivation as long as serine 396 remained available for phosphorylation. Complementation of MEFs IRF-3 KO also reveals a compensatory mechanism of serine 339 and serine 396 in the ability of IRF-3 to induce IFN-stimulated genes (ISGs) ISG56 and ISG54 expression. These data lead us to reconsider the current model of IRF-3 activation. TRAF3 is also a central mediator that is important for inducing type I interferon production in response to intracellular double-stranded RNA. By combining Flag-Affinity purification using Flag-TRAF3 as a bait to mass spectrometry, we have identified Sec16A and p115, two proteins of the ER-to-Golgi vesicular transport system, as novel TRAF3 interactors. We found that TRAF3 localizes to the ER-to-Golgi vesicular pathway and behaves like a cis-Golgi protein. Depletion of p115 or Sec16A disrupts the cis-Golgi cellular localization of TRAF3 and affects type I Interferon response following double-stranded RNA treatment. Furthermore, we demonstrate that TRAF3 colocalizes with TRADD at the cis-Golgi and also interacts with the translocon protein Sec61β in a Sec5 dependent manner. Together, our data suggest that the cellular localization of TRAF3 to the ER-to-Golgi transport compartments is required for an optimal RIG-I-like Helicases (RLH)-Cardif-dependent antiviral immune response. Our findings also highlight the potential role of the exocyst in the innate immune response. / Codirecteur de recherche: Dr Sylvain Meloche

Reverse genetics systems that are based on either viral transcripts or cDNA genome segments cloned in plasmids have recently been reported for some of the dsRNA viruses of the Reoviridae family, namely African horsesickness virus, bluetongue virus and orthoreovirus. For rotaviruses, three reverse genetics systems which only allow the manipulation of a single genome segment have been described. These rotavirus single genome segment reverse genetics systems are not true stand-alone systems because they require a helper virus and a recombinant virus selection step. A true selection-free, plasmid- only or transcript-based reverse genetics system for rotaviruses is lacking. This study sought to identify and characterise the factors that need to be understood and overcome for the development of a rotavirus reverse genetics system using mRNA derived from the in vitro transcription of a consensus nucleotide sequence as well as from double-layered particles. The consensus whole genome sequence of the prototype rotavirus DS-1 and SA11 strains was determined using sequenceindependent whole genome amplification and 454® pyrosequencing. For the rotavirus DS-1 strain, a novel isoleucine in a minor population variant was found at position 397 in a hydrophobic region of VP4. NSP1 contained seven additional amino acids MKSLVEA at the N-terminal end due to an insertion in the consensus nucleotide sequence of genome segment 5. The first 34 nucleotides at the 5'- terminus and last 30 nucleotides at the 3'-terminal end of genome segment 10 (NSP4) of the DS-1 strain were determined in this study. The consensus genome segment 11 (NSP5/6) sequence was 821 bp in length, 148 bp longer than previously reported. The 454® pyrosequence data for a rotavirus SA11 sample with no known passage history revealed a mixed infection with two SA11 strains. One of the strains was a reassortant which contained genome segment 8 (NSP2) from the bovine rotavirus O agent. The other ten consensus genome segments of the two strains could not be differentiated. Novel minor population variants of genome segments 4 (VP4), 9 (VP7) and 10 (NSP4) were identified. Molecular clock phylogenetic analyses of the rotavirus SA11 genomes showed that the two SA11 strains were closely related to the original SA11-H96 strain isolated in 1958. Plasmids containing inserts of the consensus cDNA of the rotavirus DS-1 strain were purchased and used to generate exact capped transcripts by in vitro transcription with a T7 polymerase. Wild-type transcripts of rotavirus SA11 were obtained from in vitro transcription using purified rotavirus SA11 double-layered particles. The purified rotavirus DS-1 and SA11 transcripts were transfected into BSR, COS-7 and MA104 cells. Work on MA104 cells was discontinued due their very low transfection efficacy. In BSR and COS-7 cells, rotavirus DS-1 and SA11 transcripts induced cell death. However, no viable rotavirus was recovered following attempts to infect MA104 cells with the BSR and COS-7 transfected cell lysates. The cell death was determined to be due to apoptotic cell death mechanisms. Immunostaining showed that the DS-1 genome segment 6 (VP6) and SA11 transcripts were translated in transfected BSR and COS-7 cells. Based on visual inspection, the translation seemed to be higher in the retinoic acid-inducible gene-I (RIG-I) deficient BSR cells than in COS-7 cells. This suggested that the transfection of rotavirus transcripts induced an innate immune response which could lead to the development of an antiviral state. Therefore, the innate immune response to rotavirus transcripts was investigated in HEK 293H cells using qRT-PCR and western blot analyses. Results of this investigation showed that RIG-I, but not MDA5 sensed rotavirus transcripts in transfected HEK 293H cells. Furthermore, rotavirus transcripts induced high levels of cellular mRNA encoding the cytokines IFN-1β, IFN-λ1, CXCL10 and TNF-α. Other cytokines namely, IFN-α, IL-10, IL-12 p40 and the kinase RIP1 were not significantly induced. Inhibiting the RNA-dependent protein kinase R (PKR) reduced the induction of cytokines IFN-1β, IFN-λ1, CXCL10 and TNF-α, but the expression levels were not abrogated. The importance of a consensus sequence and the insights gained in the current study regarding the role of the innate immune response after transfection of rotavirus transcripts into cells in culture, should aid the development of a true rotavirus reverse genetics system. / Thesis (PhD (Biochemistry))--North-West University, Potchefstroom Campus, 2013

Reverse genetics systems that are based on either viral transcripts or cDNA genome segments cloned in plasmids have recently been reported for some of the dsRNA viruses of the Reoviridae family, namely African horsesickness virus, bluetongue virus and orthoreovirus. For rotaviruses, three reverse genetics systems which only allow the manipulation of a single genome segment have been described. These rotavirus single genome segment reverse genetics systems are not true stand-alone systems because they require a helper virus and a recombinant virus selection step. A true selection-free, plasmid- only or transcript-based reverse genetics system for rotaviruses is lacking. This study sought to identify and characterise the factors that need to be understood and overcome for the development of a rotavirus reverse genetics system using mRNA derived from the in vitro transcription of a consensus nucleotide sequence as well as from double-layered particles. The consensus whole genome sequence of the prototype rotavirus DS-1 and SA11 strains was determined using sequenceindependent whole genome amplification and 454® pyrosequencing. For the rotavirus DS-1 strain, a novel isoleucine in a minor population variant was found at position 397 in a hydrophobic region of VP4. NSP1 contained seven additional amino acids MKSLVEA at the N-terminal end due to an insertion in the consensus nucleotide sequence of genome segment 5. The first 34 nucleotides at the 5'- terminus and last 30 nucleotides at the 3'-terminal end of genome segment 10 (NSP4) of the DS-1 strain were determined in this study. The consensus genome segment 11 (NSP5/6) sequence was 821 bp in length, 148 bp longer than previously reported. The 454® pyrosequence data for a rotavirus SA11 sample with no known passage history revealed a mixed infection with two SA11 strains. One of the strains was a reassortant which contained genome segment 8 (NSP2) from the bovine rotavirus O agent. The other ten consensus genome segments of the two strains could not be differentiated. Novel minor population variants of genome segments 4 (VP4), 9 (VP7) and 10 (NSP4) were identified. Molecular clock phylogenetic analyses of the rotavirus SA11 genomes showed that the two SA11 strains were closely related to the original SA11-H96 strain isolated in 1958. Plasmids containing inserts of the consensus cDNA of the rotavirus DS-1 strain were purchased and used to generate exact capped transcripts by in vitro transcription with a T7 polymerase. Wild-type transcripts of rotavirus SA11 were obtained from in vitro transcription using purified rotavirus SA11 double-layered particles. The purified rotavirus DS-1 and SA11 transcripts were transfected into BSR, COS-7 and MA104 cells. Work on MA104 cells was discontinued due their very low transfection efficacy. In BSR and COS-7 cells, rotavirus DS-1 and SA11 transcripts induced cell death. However, no viable rotavirus was recovered following attempts to infect MA104 cells with the BSR and COS-7 transfected cell lysates. The cell death was determined to be due to apoptotic cell death mechanisms. Immunostaining showed that the DS-1 genome segment 6 (VP6) and SA11 transcripts were translated in transfected BSR and COS-7 cells. Based on visual inspection, the translation seemed to be higher in the retinoic acid-inducible gene-I (RIG-I) deficient BSR cells than in COS-7 cells. This suggested that the transfection of rotavirus transcripts induced an innate immune response which could lead to the development of an antiviral state. Therefore, the innate immune response to rotavirus transcripts was investigated in HEK 293H cells using qRT-PCR and western blot analyses. Results of this investigation showed that RIG-I, but not MDA5 sensed rotavirus transcripts in transfected HEK 293H cells. Furthermore, rotavirus transcripts induced high levels of cellular mRNA encoding the cytokines IFN-1β, IFN-λ1, CXCL10 and TNF-α. Other cytokines namely, IFN-α, IL-10, IL-12 p40 and the kinase RIP1 were not significantly induced. Inhibiting the RNA-dependent protein kinase R (PKR) reduced the induction of cytokines IFN-1β, IFN-λ1, CXCL10 and TNF-α, but the expression levels were not abrogated. The importance of a consensus sequence and the insights gained in the current study regarding the role of the innate immune response after transfection of rotavirus transcripts into cells in culture, should aid the development of a true rotavirus reverse genetics system. / Thesis (PhD (Biochemistry))--North-West University, Potchefstroom Campus, 2013